Literature DB >> 1447321

Nonreceptor mediated nuclear accumulation of insulin in H35 rat hepatoma cells.

S Harada1, E G Loten, R M Smith, L Jarett.   

Abstract

We previously demonstrated that insulin accumulated in the nucleus in several cell types and partially characterized the uptake mechanisms and pathways in H35 rat hepatoma cells. Nuclear accumulation of insulin was energy independent, time, temperature, and insulin concentration dependent, but apparently nonsaturable. This study investigated further the initial endocytotic pathways that contribute to the nuclear accumulation of insulin using trypsin treatment of the cells to prevent insulin binding to its plasma membrane receptor. Total cell-associated, intracellular, and nuclear insulin were compared in control and trypsin-treated H35 hepatoma cells. Trypsin treatment markedly decreased total cell-associated and intracellular insulin as well as the nuclear accumulation of insulin when cells were incubated with 2.8 ng/ml insulin. When the cells were incubated with 100 ng/ml insulin, trypsin treatment totally inhibited insulin binding to the plasma membrane for at least 90 min. However, intracellular accumulation of insulin was reduced by only 50% at 60 min, and trypsin treatment failed to inhibit the nuclear accumulation of insulin. Chemical extraction and Sephadex G-50 chromatography revealed nuclear associated insulin in trypsin-treated cells was identical to that in control cells incubated with either 2.8 or 100 ng/ml insulin. These results suggest that a nonreceptor mediated uptake pathway, i.e., fluid-phase endocytosis, contributed significantly to the nuclear accumulation of insulin at high insulin concentrations, but at lower insulin concentrations the receptor-mediated pathway predominated. No matter which initial endocytotic route was used to internalize insulin, the insulin apparently associated with the same nuclear matrix proteins. This association of insulin with the nuclear matrix may be involved in regulation of nuclear events such as cell growth and differentiation or gene transcription.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447321     DOI: 10.1002/jcp.1041530323

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Insulin capture by an insulin-linked polymorphic region G-quadruplex DNA oligonucleotide.

Authors:  Adam C Connor; Kimberley A Frederick; Elizabeth J Morgan; Linda B McGown
Journal:  J Am Chem Soc       Date:  2006-04-19       Impact factor: 15.419

3.  Study on the possibility of insulin as a carrier of IUdR for hepatocellular carcinoma-targeted therapy.

Authors:  Xiao-Hong Ou; An-Ren Kuang; Xian Peng; Yu-Guo Zhong
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Nuclear accumulation of exogenous basic fibroblast growth factor in endothelial, fibroblast, and myoblast cell lines results in diverse biological responses.

Authors:  J R Hawker; H J Granger
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-10       Impact factor: 2.416

5.  Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.

Authors:  S Harada; R M Smith; J A Smith; N Shah; L Jarett
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

Review 6.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

7.  Mathematical modeling and analysis of insulin clearance in vivo.

Authors:  Markus Koschorreck; Ernst Dieter Gilles
Journal:  BMC Syst Biol       Date:  2008-05-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.